A furious debate that is raging in Brazil pits the nation’s largest university against hundreds of cancer patients who want access to a compound that some have branded a miracle cure. (Editorial)

Original Source

Order of the National Green Tribunal (Western Zone Bench, Pune) in the matter of Rabhunath & Others S/o Rakhamji Lokhane Vs. MPWPB & Ors dated 23/11/2015 regarding pollution caused by industries in Waluj, Aurangabad, Maharashtra.

Judgement of the National Green Tribunal (Western Zone Bench, Pune) in the matter of M/s. Atra Pharmaceutical Ltd. Vs Member Secretary, Maharashtra Pollution Control Board & Others dated 23/11/2015 regarding order passed by the Respondents dated July 22nd, 2015 directing Industrial unit of the Appellant to be closed and to stop manufacturing and the operation thereof.

Judgement of the National Green Tribunal in the matter of Endurance Technologies Pvt. Ltd. Vs Maharashtra Pollution control Board dated 23/11/2015 regarding closure order issued against the Appellant (Endurance Technologies Pvt. Ltd.), Waluj area, Aurangabad.

Antibiotic resistance is occurring everywhere in the world, compromising the treatment of infectious diseases and undermining many other advances in health and medicine. Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. Tackling antibiotic resistance is a high priority for WHO.

Hyderabad: Lack of regard for environmental laws by pharmaceutical companies in Telangana and Andhra Pradesh is evident yet again.

Effluents from the factory at Divya Pharmacy, belonging to yoga Guru Ramdev, at the Indira industrial estate in Haridwar city, continue to flow directly into the Ganga, near Rishikul.

Noted Supreme Court lawyer and Raman Magsaysay Award winner M.C.

A scientifically validated anti-diabetes herbal drug, named `BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) laboratory in Lucknow on Sunday .

The outrageous price rise of the 62-year-old drug, Daraprim (Pyrimethamine) has sent the United States medical fraternity into a dizzy. The price of the drug was raised from USD 13.50 to USD 750 per pill in just over a month. This obnoxious price rise of over 5,000% came after the New York-based pharmaceutical company Turing Pharmaceuticals acquired the patent for the drug from Impax Laboratories. (Editorial)

Original Source